According to the latest market research report by Technavio, the global CPAP devices market is expected to reach close to USD$4.46 billion by 2020.

In this report, Technavio covers the present scenario and growth prospects of the global continuous positive airway pressure devices market for 2016-2020. To calculate the market size, Technavio researchers have considered the revenue generated from the sales of CPAP devices and accessories. The report covers the present scenario and the growth prospects of the continuous positive airway pressure devices market in three regions:

  • Americas: The principal countries in the Americas are the US, Canada, Mexico, and Brazil
  • EMEA: The principal countries Technavio focuses on in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Kuwait, Saudi Arabia, and UAE
  • APAC: The principal countriesTechnavio focuses on in this region are Japan, China, Australia, Singapore, South Korea, and India

“The Americas dominated the global continuous positive airway pressure devices market in 2015, followed by EMEA and APAC, with the US accounting for close to 58.75% of the market share. In the Americas, the US market is witnessing an increase in diagnosis of sleep apnea in patients,” says Barath Palada, one of Technavio’s lead industry analysts for orthopedics and general medical devices, in a release.

“It is estimated that more than 18 million adults in the US have sleep apnea. However, it is difficult to measure the prevalence of sleep apnea among children, and it is a factor that showcases the untapped potential of this market. With growing awareness of the condition, development of home sleep testing devices will provide further impetus for market growth over the next four years,” says Palada.

Segmentation of global continuous positive airway pressure devices market by geography 2015

Americas: 58.57%
EMEA: 27.81%
APAC: 13.44%

Americas: largest region for the global continuous positive airway pressure devices market

The CPAP devices market in the Americas was valued at USD$1.88 billion. The CPAP devices market in the Americas is expected to grow at a steady pace during the forecast period. Awareness among the region’s population and technological advances are the primary factors for high adoption of respiratory devices in hospitals and homes in the Americas.

Devices used to treat patients at their home helps them save costs, while treatment in sleep labs is both time-consuming and expensive. In the US, about 35%–40% of sleep tests are conducted at patient homes. ResMed and Philips Healthcare are some of the major players in the US, and they account for close to 85% of the market in 2015.

EMEA: second largest region for the global continuous positive airway pressure devices market

The CPAP devices market in EMEA was valued at USD$0.89 billion in 2015. Continuous positive airway pressure devices market in EMEA is expected to grow at a faster pace during the forecast period. Increasing aging population and technological advances in this region are the primary causes for the high adoption of continuous positive airway pressure devices in hospitals and homes.

The availability of reimbursement, increasing awareness of respiratory diseases, and a strong presence of several vendors also play a significant role in increasing the demand for continuous positive airway pressure devices.

Continuous positive airway pressure devices market in APAC

The CPAP devices market in APAC was valued at USD$0.43 billion in 2015. Although APAC accounts for only a small share in the global market, the region has the highest growth rate. Increasing awareness and rising spending power among emerging countries in this region is expected to significantly augment its demand over the next four years. Though most countries in the region do not support reimbursement, improved healthcare infrastructure, increase in healthcare investment by private entities, and availability of low-cost products will primarily drive market growth.